Turning a blind eye:Testing the success of blinding and the CONSORT statement

BMJ

Volumn 328, Issue 7448, 2004, Pages 1135-

  Altman, Douglas G ^a   Schulz, Kenneth F ^b   Moher, David ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b FAMILY HEALTH INTERNATIONAL   (United States)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; METHODOLOGY; NOTE; RANDOMIZED CONTROLLED TRIAL;

DOUBLE-BLIND METHOD; RANDOMIZED CONTROLLED TRIALS;

EID: 2342475085     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.328.7448.1135-a     Document Type: Letter

References (5)

1. Moher D, Schulz KF Altman DG for the CONSORT. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191–4.
2. Fergusson D, Cranley Glass K, Waring D, Shapiro S. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ 2004; 328: 432. (21 February.)
3. Schulz KF, Chalmers I, Altman DG. The landscape and lexicon of blinding in randomized trials. Ann Intern Med 2002; 136: 254–9.
4. Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002; 359: 696–700.
5. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663–94.